CGCI: HIV+ Tumor Molecular Characterization Project (HTMCP) – Diffuse Large B-cell Lymphoma (DLBCL)
Source: NCBI BioProject (ID PRJNA172565)

0 0

Project name: Homo sapiens
Description: The Office of Cancer Genomics at the National Cancer Institute is sponsoring a series of studies as part of the Cancer Genome Characterization Initiative (CGCI) to assess novel emerging sequencing technologies in cancer. The CGCI program includes comprehensive characterization of the genetic aberrations found in different pediatric and/or adult tumors. All data from these projects will be released into publicly accessible databases, with a majority of data in an open-access tier. A subset of data will be available only through a controlled-access tier due to patient privacy concerns. CGCI is currently characterizing a number of HIV-associated tumors (including DLBCL, lung and cervical cancers). As part of CGCI, this project is a joint effort of the Office of Cancer Genomics (OCG) and the Office of HIV and AIDS Malignancy (OHAM). Its goals are to characterize HIV-associated cancers (obtained from HIV-infected patients) and compare them to the same types... (for more see dbGaP study page.)
Data type: Phenotype or Genotype
Sample scope: Multiisolate
Relevance: Medical
Organization: NIH
Statistics: 11 samples; 14 experiments; 14 runs